The DPT-1 trial: A negative result with lessons for future type 1 diabetes prevention

Diabetes/Metabolism Research and Reviews

Volumn 18, Issue 4, 2002, Pages 257-259

  Pozzilli, Paolo ^a,b,c  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^c University Campus BioMedico ^*  (Italy)

Author keywords

Immunointervention; Insulin; Prevention; Type 1 diabetes

Indexed keywords

AUTOANTIBODY; C PEPTIDE; INSULIN;

ANTIBODY SCREENING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EARLY DIAGNOSIS; EDITORIAL; FEASIBILITY STUDY; FOLLOW UP; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KETOACIDOSIS; PREDICTION; PRIORITY JOURNAL; RELATIVE; RISK ASSESSMENT; TREATMENT OUTCOME; TREATMENT PLANNING;

CLINICAL TRIALS; DIABETES MELLITUS, TYPE 1; HUMANS; RESEARCH DESIGN;

EID: 0036657189     PISSN: 15207552     EISSN: None     Source Type: Journal    
DOI: 10.1002/dmrr.316     Document Type: Editorial

References (10)

1. Diabetes Prevention Trial - Type 1 Diabetes Study Group. Effects of insulin in relatives of patients with type 1 diabetes mellitus. N Engl J Med 2002; 346: 1685-1691.
2. Keller RJ, Eisenbarth GS, Jackson RA. Insulin prophylaxis in individuals at high risk of type I diabetes mellitus. Lancet 1993; 341: 927-928.
3. Gotfredsen GF, Buschard K, Frandsen EK. Reduction of diabetes incidence of BB Wistar rats by early prophylactic insulin treatment of diabetes-prone animals. Diabetologia 1985; 28: 933-935
4. Vlahos WD, Seemayer TA, Yale JF. Diabetes prevention in BB rats by inhibition of endogenous insulin secretion. Metabolism 1991; 40: 825-829.
5. Bowman MA, Campbell L, Darrow BL, et al. Immunological and metabolic effects of prophylactic insulin therapy in NOD-scid/scid adoptive transfer model of IDDM. Diabetes 1996; 45: 20S-208.
6. Miller AM, Lider O, Weiner HL. Antigen-driven bystander suppression after oral administration of antigens. J Exp Med 1991; 174: 791-798.
7. Gladstone P, Nepon GT. The prevention of IDDM: injecting insulin into the cytokine network. Diabetes 1995; 44: 859-862.
8. Aaen K, Rygard J, Josenson K, et al. Dependence of antigen expression on functional state of cells. Diabetes 1990; 39: 697-701.
9. Herold KC, Hagopian W, Auger JA, et al. Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. N Engl J Med 2002; 346: 1692-1698.
10. Klein R, Klein BEK, Moss SC. The Wisconsin epidemiologic study of diabetic retinopathy. The relationship of C-peptide to the incidence and progression of diabetic retinopathy. Diabetes 1995; 44: 796-801.